CCRN
Cross Country Healthcare Inc
13.30$
+0.0%
vs. previous close
Closing price · As of: Jul 28, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -41.0% | -82.8% | -50.2% | +1,270.8% | -90.9% | +224.4% | -76.6% | -25.8% | +377.0% | -9.3% | -73.9% | – | |
| – | +2.4% | -1.5% | +3.8% | +1.7% | -4.7% | -3.5% | +9.9% | -14.1% | -0.3% | -6.2% | -4.3% | – | |
| – | -35.0% | -18.6% | +2.7% | +88.6% | -61.5% | +95.2% | -22.4% | -34.0% | -12.0% | +447.0% | -72.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -45.8% | -116.6% | – | – | -194.8% | – | -97.8% | +1,032.0% | +333.4% | -85.2% | +5.2% | – | |
| – | -14.3% | -16.1% | -23.1% | +28.9% | -60.5% | +125.2% | -25.5% | +4.3% | +11.4% | -3.4% | -31.1% | – | |
| – | -14.7% | -15.6% | -23.1% | +28.9% | -60.5% | +125.2% | -25.5% | +4.3% | +11.4% | -3.4% | -31.1% | – | |
| – | +212.7% | -56.6% | -0.5% | +134.7% | -20.2% | -65.8% | -92.3% | +459.2% | -99.7% | +108,550.0% | -10.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -53.6% | -88.0% | +144.0% | -2.9% | -21.5% | -65.8% | +15.9% | -62.8% | -99.7% | +108,550.0% | -1.0% | – | |
| – | +3,467.5% | -79.5% | -524.3% | – | -108.7% | – | -105.3% | – | +3,516.7% | -46.5% | -132.8% | – | |
| – | -42.0% | -86.2% | -58.7% | +1,992.9% | -92.0% | +242.0% | -82.5% | -40.7% | +696.6% | -10.0% | -79.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.